Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Applied Dna Sciences Inc (APDN)

Applied Dna Sciences Inc (APDN)
1.1100 x 1,500 1.1800 x 1,000
Post-market by (Cboe BZX)
1.1500 +0.0500 (+4.55%) 04/11/25 [NASDAQ]
1.1100 x 1,500 1.1800 x 1,000
Post-market 1.1100 -0.0400 (-3.48%) 19:59 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.0200
Day High
1.3200
Open 1.1100
Previous Close 1.1000 1.1000
Volume 1,596,800 1,596,800
Avg Vol 3,254,420 3,254,420
Stochastic %K 8.46% 8.46%
Weighted Alpha -98.37 -98.37
5-Day Change -0.3000 (-20.69%) -0.3000 (-20.69%)
52-Week Range 1.0200 - 397.0000 1.0200 - 397.0000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,269
  • Shares Outstanding, K 1,104
  • Annual Sales, $ 3,430 K
  • Annual Income, $ -6,990 K
  • EBIT $ -13 M
  • EBITDA $ -13 M
  • 60-Month Beta 0.86
  • Price/Sales 0.35
  • Price/Cash Flow N/A
  • Price/Book 0.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -265.50
  • Growth Rate Est. (year over year) +476.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0200 +12.75%
on 04/11/25
Period Open: 7.3500
5.0000 -77.00%
on 03/12/25
-6.2000 (-84.35%)
since 03/11/25
3-Month
1.0200 +12.75%
on 04/11/25
Period Open: 9.8850
10.5000 -89.05%
on 01/23/25
-8.7350 (-88.37%)
since 01/10/25
52-Week
1.0200 +12.75%
on 04/11/25
Period Open: 381.0000
397.0000 -99.71%
on 04/12/24
-379.8500 (-99.70%)
since 04/11/24

Most Recent Stories

More News
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

STONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a...

APDN : 1.1500 (+4.55%)
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases -

APDN : 1.1500 (+4.55%)
Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical...

APDN : 1.1500 (+4.55%)
Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect...

APDN : 1.1500 (+4.55%)
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

Applied DNA Sciences: Fiscal Q1 Earnings Snapshot

APDN : 1.1500 (+4.55%)
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

- Announces Exit of DNA Tagging and Security Products and Services Business Segment -

APDN : 1.1500 (+4.55%)
Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Investor Call and Webcast Scheduled for 4:30 P.M ET

APDN : 1.1500 (+4.55%)
Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its...

APDN : 1.1500 (+4.55%)
Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

- Signals Start of New Commercialization Phase for LineaRx Subsidiary -

APDN : 1.1500 (+4.55%)
Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...

APDN : 1.1500 (+4.55%)

Business Summary

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market,...

See More

Key Turning Points

3rd Resistance Point 1.6067
2nd Resistance Point 1.4633
1st Resistance Point 1.3067
Last Price 1.1500
1st Support Level 1.0067
2nd Support Level 0.8633
3rd Support Level 0.7067

See More

52-Week High 397.0000
Fibonacci 61.8% 245.7356
Fibonacci 50% 199.0100
Fibonacci 38.2% 152.2844
Last Price 1.1500
52-Week Low 1.0200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar